Maria Grant, M.D., Professor and Eivor and Alston Callahan, M.D., Endowed Chair in Ophthalmology and UAB Comprehensive Diabetes Center scientist, was awarded the Research to Prevent Blindness (RPB) David F. Weeks Award for Outstanding Vision Research at the Association of University Professors of Ophthalmology (AUPO) annual meeting.

Andrew Hardaway, Ph.D., assistant professor in the UAB Department of Psychiatry and Behavioral Neurobiology, has been chosen as a 2025 Pittman Scholar by the UAB Heersink School of Medicine.

Glucagon-like peptide-1 (GLP-1) receptor agonists and dual agonists have changed the treatment landscape of obesity and Type 2 diabetes (T2D), but significant limitations have emerged due to their gastrointestinal side effects, loss of lean mass, and necessity for ongoing subcutaneous injections.

UAB Comprehensive Diabetes Center (UCDC) Director Anath Shalev, M.D., presented the annual Ray A. and Robert L.

W. Timothy Garvey, M.D., associate director of the UAB Comprehensive Diabetes Center (UCDC) and director and principal investigator of the NIH-funded UAB Diabetes Research Center (DRC), was awarded the Gerald Reaven Distinguished Leader in Insulin Resistance Award by the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC).

The UAB Comprehensive Diabetes Center welcomes Amy W. Richardson as the center's new communications manager.

Jeonga Kim, Ph.D., and collaborators, published “Endothelial autophagy-related gene 7 contributes to high fat diet-induced obesity” in the peer-reviewed journal Molecular Metabolism.

Garvey’s career spans decades of influential work, shaping national guidelines for obesity and diabetes treatment.

Sushant Bhatnagar, Ph.D. (left) and Brooks Vaughan, M.D.

Members of the UAB Comprehensive Diabetes Center (UCDC) participated in the UAB Core and Shared Resources Day 2025 on January 7.

The commission recommends a shift away from relying solely on BMI to more accurately define obesity as a disease.

The University of Alabama at Birmingham (UAB) was recently ranked in the top 6% of global universities by U.S. News & World Report (USNWR).

As we begin a new year, the UAB Comprehensive Diabetes Center has compiled key conference and grant submission dates for 2025.

Scientists at the University of Alabama at Birmingham (UAB) Comprehensive Diabetes Center have characterized a molecular tool that will allow researchers to further study long-term glucagon action and glucagon receptor signaling. 

UAB Comprehensive Diabetes Center Member and Division of Endocrinology, Diabetes, and Metabolism Associate Professor Anish Patel, M.D., recently sat down with UAB MedCast podcast to talk about the telehealth and diabetes.

The University of Alabama at Birmingham’s (UAB) Harbert Institute for Innovation and Entrepreneurship (HIIE) celebrated its annual Innovation Awards on October 11, 2024, recognizing outstanding innovators and entrepreneurial achievements.

Justin Alexander is the Lab Manager and a Researcher in the lab of Sushant Bhatnagar, Ph.D. He recieved his undergraduate degree from Auburn University.

A UAB expert explains what a certified diabetes and education specialist is and how they can benefit patients with diabetes.

UAB Comprehensive Diabetes Center Member and Division of Pediatric Endocrinology & Diabetes Assistant Professor Jessica Schmitt, M.D., recently sat down with UAB MedCast podcast to talk about treating pediatric patients with Type 1 diabetes.

UAB Division of Endocrinology, Diabetes, and Metabolism Associate Professor and Scientist in the Comprehensive Diabetes Center Sushant Bhatnagar, Ph.D., was awarded a prestigious one-year R56 grant from the National Institutes of Health (NIH).

The scientific journal Frontiers in Endocrinology just published a peer-reviewed perspective article by UAB Comprehensive Diabetes Center (UCDC) Director Anath Shalev, M.D., entitled “A novel class of oral, non-immunosuppressive, beta cell-targeting, TXNIP-inhibiting T1D drugs is emerging”. Other authors from the Shalev Lab include Gu Jing, Ph.D., and SeongHo Jo, Ph.D.

Congressman Gary Palmer (AL-06) toured the UAB Comprehensive Diabetes Center (UCDC) on Wednesday, September 4, to learn more about the state of diabetes in Alabama.

Sasanka Ramanadham, Ph.D., and collaborators, published an article entitled “Differential lipid signaling from CD4+ and CD8+ T cells contributes to Type 1 (T1D) diabetes development” in the peer-reviewed journal Frontiers in Immunology.

UAB Comprehensive Diabetes Center Member and Division of Endocrinology, Diabetes, and Metabolism Assistant Professor Fernando Bril, M.D., recently sat down with UAB MedCast podcast to talk about metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes.

A cluster analysis in the Deep South showed that racial background significantly influences diabetes subtype distribution.

The novel drug TIX100 functions differently from any approved diabetes drug to promote proper islet cell function.

UAB researchers say the presented data indicates that a younger age and higher HbA1c at baseline predict early treatment failure and point to the need for more aggressive initial treatment in these patients.

A healthy lifestyle is about small changes over time that build upon each other.

Lund is the fifth Distinguished Fellow from UAB named since 2019, a sign of the strength of immunology research at UAB.

From January to May of 2023, Shelby Lyda, M.D., was extremely tired and had brain fog, but she chalked it up to the demands of a residency program.